Yikes. You really should look deeper than Yahoo for your DD.
1) they don't have 199 mil shares out.
2) they have more $ now than 19 mil.
3) they are already in the middle of (possibly near end?) of Phase III trial.
4) a 2nd confirmation PhIII may be needed with ~200 people. They could maybe pull this off without raising more cash...or they could partner.
It was only a matter of time before speeddog made up a strawman, complete with easy to refute assertions to help everyone feel superior to "the shorts"
Oncy management has not been particularly dilutive, keeping a small staff and spending trial money wisely.
I dont have a problem w management, I think they are doing the best they can w a bad hand (Reo).
I do not that longs are dishonestly suggesting the head and neck trial is near to allowing FDA approval. They will do this until the company announced a registrational phase III trial, at which time longs will switch to pretending the new trial will take no time.
Benefit of the doubt, one last time. The balance sheet reports dollars, not share counts. Since the "common stock" value did look high, I went to the actual financials (on ONCY's site) and learned that their stock is no-par. That means that it is booked at the values paid for it rather than being split between a tiny "par value" and "additional paid-in capital". Still, the share count is somewhere in the vicinity of 85 million shares. End of story.